Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

HyaloFAST Trial for Repair of Articular Cartilage in the Knee

NCT: NCT02659215 · ACTIVE_NOT_RECRUITING

NCT IDNCT02659215
StatusACTIVE_NOT_RECRUITING
Start Date2015-12
Completion2026-06-30

Brief Summary

The purpose of this study is to evaluate the safety and efficacy of Hyalofast® scaffold with bone marrow aspirate concentrate (BMAC) compared to microfracture in the treatment of symptomatic cartilage defects of the knee.

Frequently Asked Questions

What is HyaloFAST Trial for Repair of Articular Cartilage in the Knee?

HyaloFAST Trial for Repair of Articular Cartilage in the Knee is a clinical trial registered under NCT02659215. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT02659215?

The current status of NCT02659215 (HyaloFAST Trial for Repair of Articular Cartilage in the Knee) is: ACTIVE_NOT_RECRUITING.

When did HyaloFAST Trial for Repair of Articular Cartilage in the Knee start?

HyaloFAST Trial for Repair of Articular Cartilage in the Knee started on 2015-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑